...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM Corporation Update Slides and Webcast
Reply New Message
Back To Forum List View
Icon president Zenith AGM Corporation Update Slides and Webcast
2
BearDownAZ
Oct 31, 2019 09:01PM
Icon president Re: Zenith AGM Corporation Update Slides and Webcast
7
BearDownAZ
Oct 31, 2019 10:54PM
Re: Zenith AGM Corporation Update Slides and Webcast
9
RVXoldtimer
Nov 01, 2019 02:46AM
Icon president Re: Zenith AGM Corporation Update Slides and Webcast
1
BearDownAZ
Nov 01, 2019 07:02AM
Re: Zenith AGM Corporation Update Slides and Webcast
5
narmac
Nov 01, 2019 09:16AM
Re: Zenith AGM Corporation Update Slides and Webcast
4
rocketman2
Nov 01, 2019 09:51AM
Re: Zenith AGM Corporation Update Slides and Webcast
4
Mazola
Nov 01, 2019 07:25PM
Icon president Re: Zenith AGM Corporation Update Slides and Webcast
5
Toinv
Nov 02, 2019 03:00PM
Re: Zenith AGM Corporation Update Slides and Webcast
4
narmac
Nov 03, 2019 01:56PM
Re: Zenith AGM Corporation Update Slides and Webcast
5
Albertaclipper
Nov 03, 2019 03:31PM
Re: Zenith AGM Corporation Update Slides and Webcast
3
KOO-KOO2
Nov 03, 2019 04:45PM

"Phase 2a mCRPC trial (AR inhibitor resistant) nearing completion. Expected to be officially done November 2019. Last patient visit 11/19."

Could be some big news coming out of Zenith on the mCRPC trial soon.

2 Recommendations
Re: Zenith AGM Corporation Update Slides and Webcast
3
Nextblockbuster
Nov 20, 2019 11:14AM
Icon president Re: Zenith AGM Corporation Update Slides and Webcast
6
BearDownAZ
Nov 20, 2019 11:46AM
Re: Zenith AGM Corporation Update Slides and Webcast
5
Nextblockbuster
Nov 20, 2019 01:15PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply